185 related articles for article (PubMed ID: 15226503)
1. The bioactive Taxol conformation on beta-tubulin: experimental evidence from highly active constrained analogs.
Ganesh T; Guza RC; Bane S; Ravindra R; Shanker N; Lakdawala AS; Snyder JP; Kingston DG
Proc Natl Acad Sci U S A; 2004 Jul; 101(27):10006-11. PubMed ID: 15226503
[TBL] [Abstract][Full Text] [Related]
2. Rotational-echo double-resonance NMR distance measurements for the tubulin-bound Paclitaxel conformation.
Paik Y; Yang C; Metaferia B; Tang S; Bane S; Ravindra R; Shanker N; Alcaraz AA; Johnson SA; Schaefer J; O'Connor RD; Cegelski L; Snyder JP; Kingston DG
J Am Chem Soc; 2007 Jan; 129(2):361-70. PubMed ID: 17212416
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the tubulin-bound paclitaxel conformation: synthesis, biology, and SAR studies of C-4 to C-3' bridged paclitaxel analogues.
Ganesh T; Yang C; Norris A; Glass T; Bane S; Ravindra R; Banerjee A; Metaferia B; Thomas SL; Giannakakou P; Alcaraz AA; Lakdawala AS; Snyder JP; Kingston DG
J Med Chem; 2007 Feb; 50(4):713-25. PubMed ID: 17263521
[TBL] [Abstract][Full Text] [Related]
4. The tubulin-bound conformation of paclitaxel: T-taxol vs "PTX-NY".
Yang Y; Alcaraz AA; Snyder JP
J Nat Prod; 2009 Mar; 72(3):422-9. PubMed ID: 19267457
[TBL] [Abstract][Full Text] [Related]
5. The taxol pharmacophore and the T-taxol bridging principle.
Kingston DG; Bane S; Snyder JP
Cell Cycle; 2005 Feb; 4(2):279-89. PubMed ID: 15611640
[TBL] [Abstract][Full Text] [Related]
6. Insights into the mechanism of microtubule stabilization by Taxol.
Xiao H; Verdier-Pinard P; Fernandez-Fuentes N; Burd B; Angeletti R; Fiser A; Horwitz SB; Orr GA
Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10166-10173. PubMed ID: 16801540
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of simplified taxol analogs based on the T-Taxol bioactive conformation.
Zhao J; Bane S; Snyder JP; Hu H; Mukherjee K; Slebodnick C; Kingston DG
Bioorg Med Chem; 2011 Dec; 19(24):7664-78. PubMed ID: 22071526
[TBL] [Abstract][Full Text] [Related]
8. The T-Taxol conformation.
Alcaraz AA; Mehta AK; Johnson SA; Snyder JP
J Med Chem; 2006 Apr; 49(8):2478-88. PubMed ID: 16610791
[TBL] [Abstract][Full Text] [Related]
9. The binding conformation of Taxol in beta-tubulin: a model based on electron crystallographic density.
Snyder JP; Nettles JH; Cornett B; Downing KH; Nogales E
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5312-6. PubMed ID: 11309480
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and bioactivity of a side chain bridged paclitaxel: A test of the T-Taxol conformation.
Hodge M; Chen QH; Bane S; Sharma S; Loew M; Banerjee A; Alcaraz AA; Snyder JP; Kingston DG
Bioorg Med Chem Lett; 2009 May; 19(10):2884-7. PubMed ID: 19359169
[TBL] [Abstract][Full Text] [Related]
11. T-Taxol and the electron crystallographic density in beta-tubulin.
Johnson SA; Alcaraz AA; Snyder JP
Org Lett; 2005 Dec; 7(25):5549-52. PubMed ID: 16320988
[TBL] [Abstract][Full Text] [Related]
12. Computational comparison of microtubule-stabilising agents laulimalide and peloruside with taxol and colchicine.
Pineda O; Farràs J; Maccari L; Manetti F; Botta M; Vilarrasa J
Bioorg Med Chem Lett; 2004 Oct; 14(19):4825-9. PubMed ID: 15341932
[TBL] [Abstract][Full Text] [Related]
13. Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes.
Derry WB; Wilson L; Khan IA; Luduena RF; Jordan MA
Biochemistry; 1997 Mar; 36(12):3554-62. PubMed ID: 9132006
[TBL] [Abstract][Full Text] [Related]
14. Expression of recombinant alpha and beta tubulins from the yew Taxus cuspidata and analysis of the microtubule assembly in the presence of taxol.
Kudo Y; Abe A; Ito K; Cho Y; Yotsu-Yamashita M; Konoki K
Biosci Biotechnol Biochem; 2014; 78(11):1887-94. PubMed ID: 25070196
[TBL] [Abstract][Full Text] [Related]
15. The solid state, solution and tubulin-bound conformations of agents that promote microtubule stabilization.
Jiménez-Barbero J; Amat-Guerri F; Snyder JP
Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):91-122. PubMed ID: 12678753
[TBL] [Abstract][Full Text] [Related]
16. Conformation of microtubule-bound paclitaxel determined by fluorescence spectroscopy and REDOR NMR.
Li Y; Poliks B; Cegelski L; Poliks M; Gryczynski Z; Piszczek G; Jagtap PG; Studelska DR; Kingston DG; Schaefer J; Bane S
Biochemistry; 2000 Jan; 39(2):281-91. PubMed ID: 10630987
[TBL] [Abstract][Full Text] [Related]
17. Taxol (paclitaxel): mechanisms of action.
Horwitz SB
Ann Oncol; 1994; 5 Suppl 6():S3-6. PubMed ID: 7865431
[TBL] [Abstract][Full Text] [Related]
18. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E
Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889
[TBL] [Abstract][Full Text] [Related]
19. Use of the tubulin bound paclitaxel conformation for structure-based rational drug design.
Geney R; Sun L; Pera P; Bernacki RJ; Xia S; Horwitz SB; Simmerling CL; Ojima I
Chem Biol; 2005 Mar; 12(3):339-48. PubMed ID: 15797218
[TBL] [Abstract][Full Text] [Related]
20. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.
Kavallaris M; Kuo DY; Burkhart CA; Regl DL; Norris MD; Haber M; Horwitz SB
J Clin Invest; 1997 Sep; 100(5):1282-93. PubMed ID: 9276747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
